WHO South-East Asia Journal of Public Health
  • 513
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price

Roughead Elizabeth E, Kim Dong-Sook, Ong Benjamin, Kemp-Casey Anna

Year : 2018| Volume: 7| Issue : 2 | Page no: 99-106

   This article has been cited by
1 Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility
Seung Mi Lee,Heui Jae Kim,David Suh,Kyung-In Joung,Eun Suk Kim,Hee Jung Back,Jun Young Kwon,Man-Jae Park,Dong Churl Suh
BMC Health Services Research. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
2 Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
Konstantin Tachkov,Zornitsa Mitkova,Vladimira Boyadzieva,Guenka Petrova
Pharmaceuticals. 2021; 14(1): 64
[Pubmed]  [Google Scholar] [DOI]
3 Application of Australian Pharmaceutical Benefits Scheme data to the drug utilization studies: A case analysis on atorvastatin
Hye-Jae Lee,Su-Yeon Yu
Korean Journal of Clinical Pharmacy. 2020; 30(2): 73
[Pubmed]  [Google Scholar] [DOI]


Read this article